Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun 13;17(9):1377-82.
doi: 10.1097/00002030-200306130-00012.

Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia

Elizabeth M Stringer  1 , Moses Sinkala, Jeffrey S Stringer, Elizabeth Mzyece, Ida Makuka, Robert L Goldenberg, Pascal Kwape, Martha Chilufya, Sten H Vermund
Affiliations

Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia

Elizabeth M Stringer et al. AIDS. .

Abstract

Background: Nearly half of perinatal HIV infection is preventable with nevirapine (NVP), which has transformed the ability to confront this transmission route in resource-limited settings.

Methods: A NVP-based perinatal HIV prevention program initiated in Lusaka, Zambia in November 2001.

Results: The first 12 months cost US$221 000 and enabled 178 district health employees to be trained in voluntary counseling and testing: 17 263 pregnant women were counseled for HIV, 12 438 (72%) were tested, and 2924 (24%) were found to be infected with HIV. NVP has been taken by 1654 (57%) mothers and 1157 (40%) babies. It is estimated that at least 190 infants have been spared HIV infection (11 per 1000 counseled women or 65 per 1000 identified HIV-infected women).

Conclusions: Prevention of mother-to-child HIV transmission is feasible and cost effective in resource-limited settings. In Lusaka, thousands of women have received voluntary counseling and testing and NVP therapy under the present scheme. Patient attrition and non-adherence represented a major source of program inefficiency, which requires to be systematically addressed.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Stamp placed in maternal antenatal record for documenting HIV pre-test counseling, acceptance or refusal of testing, HIV status, and receipt of maternal and infant nevirapine
PCR, patient counseled and refused testing (will be approached again at a subsequent visit); PCA, patient counseled and accepted testing; R, reactive (HIV-infected); NR, non-reactive (HIV uninfected); I, indeterminate; RMd, reactive, mother given the drug; RBd, reactive, baby given the drug.
See this image and copyright information in PMC

References

    1. Fylkesnes K, Musonda R, Kasumba K, Mubanga, Musonda R, Sichone M. The HIV epidemic in Zambia: socio-demographic prevalence patterns and indications of trends among childbearing women. AIDS. 1997;11:339–345. - PubMed
    1. Stringer J, Sinkala M, Stout J, Acosta EP, Chapman V, Kumwenda, et al. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J AIDS. 2003 in press. - PMC - PubMed
    1. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–1182. - PubMed
    1. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354:795–802. - PubMed
    1. Boerhringer-Ingelheim VIRAMUNE® Donation Programme for the Prevention of Mother-to-Child Transmission of HIV-1. http://www.viramune-donation-program.org, Accessed May 31, 2002.

Publication types

MeSH terms